sildenafil pharmacie tetracycline sans ordonnance periactin vente pas cher atarax acheter ibuprofen online dapoxetine sur le comptoir zyrtec sur le comptoir propecia pas cher paris metformin générique vardenafil sur le comptoir
viagra generico con contrassegno acheter levitra generique viagra le prix viagra farmacia ahumada viagra generique 48 h chrono pastillas cialis como comprar cialis farmacia viagra viagra ou cialis prix acheter viagra femme

Taking aspirin once a month reduces cancer risk

Mon, Apr 1, 2013

Oral Cancer News

Source: www.ghanaweb.com
Author: staff

Popping an aspirin just once a month could cut people’s chances of developing cancer by almost a quarter, new research suggests. According to scientists at Queen’s University in Belfast, a weekly or even monthly dose of the over-the-counter painkiller could help people avoid developing tumours.

Their investigation indicated that a regular dose of aspirin could reduce people’s risk of getting head and neck cancer by 22 per cent. A regular dose of aspirin in middle age is already recognised as helping to reduce people’s risk of heart attacks and strokes.

Academics at the Belfast university carried out an investigation into the impact of aspirin and ibuprofen on head and neck cancer risk, a report in the Daily Express said.

It was most effective in throat cancer prevention, their study showed.

The results of their research were published in the British Journal of Cancer. They concluded that aspirin ‘may have potential as a chemopreventive agent’, noting that ‘further investigation is warranted’. Head and neck cancers affect more than 16,000 people in the UK annually.

Dr Nigel Carter, chief executive of the British Dental Health Foundation, said the research was ‘encouraging’

‘Regular aspirin use has been linked to preventing a number of cancers, and if it is a particularly successful practice for warding off mouth cancer, it should act as a springboard for more research,’ he said.

Print Friendly
Be Sociable, Share!

Leave a Reply

You must be logged in to post a comment.